JD Bioscience Establishes R&D Collaboration with Astellas to Advance Innovative Therapies. > News_and_Media

본문 바로가기
사이트 내 전체검색
닫기

News and Media

HomeNews and Media

News and Media

Nov 20, 2026

News

JD Bioscience Establishes R&D Collaboration with Astellas to Advance Innovative Therapies.

작성자 최고관리자 댓글 0건 조회view 73 작성일 26-11-20 15:11

본문

JD Bioscience Establishes R&D Collaboration with Astellas to Advance Innovative Therapies.


International collaboration aims to advance research and development about 

inflammatory disease through strategic partnership


Seoul, South Korea, November 20, 2026 — JD Bioscience Inc., a South Korean biotechnology company developing innovative therapeutics for inflammatory and fibrotic diseases, today 

announced a research and development collaboration with Astellas Pharma Inc. (Astellas), a 

global pharmaceutical company, through an international collaborative R&D project supported by 

the Korea Technology and Information Promotion Agency (TIPA) of South Korea.


The collaboration will bring together the complementary expertise and capabilities of both 

companies to support the advancement of innovative therapeutic approaches for inflammatory 

disease. 


Through this international collaborative R&D project, the parties aim to generate scientific insights and development data that may support future partnering or licensing opportunities related to the 

results of the Project, subject to the terms of the collaboration agreement.


The collaboration with Astellas represents an important step in JD Bioscience's strategy to 

expand its global partnerships and advance its research programs through collaboration.



Professor Jin Hee Ahn, CEO of JD Bioscience, commented:


“We are pleased to establish this collaboration with Astellas. We believe that combining our 

research capabilities with Astellas' pharmaceutical development expertise will create valuable 

opportunities to advance innovative therapeutic approaches for patients. 


This collaboration also represents an important milestone in our efforts to build global partnerships and translate our research into potential new treatment options. JD Bioscience is fully committed 

to working closely with Astellas to make this collaboration a success.  



About JD Bioscience


JD Bioscience is a South Korean biotechnology company focused on discovering and developing innovative therapeutics for inflammatory, fibrotic, metabolic, and other diseases with significant 

unmet medical needs. 


The company is advancing a pipeline of small-molecule drug candidates and development-stage 

therapeutic platforms across multiple disease areas, including metabolic dysfunction-associated 

steatohepatitis (MASH), inflammatory bowel disease (IBD), and other inflammation- and metabolism-related disorders. JD Bioscience is also expanding its oncology research through the development of novel small-molecule payloads and actively pursuing global partnerships to accelerate 

the development and commercialization of its programs.



Media & Business Development Contact


JD Bioscience Inc.


Business Development Team
 
 

회원로그인

회원가입

사이트 정보

회사명 : 회사명 / 대표 : 대표자명
주소 : OO도 OO시 OO구 OO동 123-45
사업자 등록번호 : 123-45-67890
전화 : 02-123-4567 팩스 : 02-123-4568
통신판매업신고번호 : 제 OO구 - 123호
개인정보관리책임자 : 정보책임자명

  • 게시물이 없습니다.

접속자집계

오늘
225
어제
582
최대
1,321
전체
446,862
Privacy policy

COPYRIGHT(C) 2021 JD BIOSCIENCE INC. ALL RIGHT RESERVED